C4 Therapeutics

chop down cut tree chainsaw ax
Biotech

C4T halts BRAF degrader work to save cash for cemsidomide

C4 Therapeutics is ending work on its clinical-stage BRAF degrader program to focus on its IKZF1/3 degraded cemsidomide.
James Waldron May 7, 2025 7:00am
Parachute over La Jolla California

Less than a year in, BenevolentAI CEO is out—Chutes & Ladders

Oct 18, 2024 8:30am
milkshake ice cream diner dessert open for two cheers

Merck KGaA paying $16M to join C4's protein degrader hunt

Mar 4, 2024 10:18am
Graphic image of someone cutting off a row of stick figures symbolizing employees

C4 lays off 30% of staff in aftermath of halting cancer drug

Jan 10, 2024 5:24am
Graphic image of a pen signing a signature while two strangelooking business people cheer

Merck offers up to $610M for one of C4’s protein degraders

Dec 12, 2023 10:30am
plan B fail reroute road path trail miss

C4 culls phase 1/2 cancer program after efficacy fail

Nov 1, 2023 11:29am